ImmunoGen Inc.

NASDAQ: IMGN · Real-Time Price · USD
31.23
0.00 (0.00%)
At close: Feb 09, 2024, 9:58 PM

ImmunoGen Revenue

ImmunoGen reported an annual revenue of $108.78M, reflecting a 55.72% growth. For the quarter ending September 30, 2023, ImmunoGen generated $113.42M in revenue.
Revenue (ttm)
108.78M
Revenue Growth
55.72%
Price / Sales Ratio
11.56
Revenue / Employee
392.71K
Employees
277
Market Cap
8.73B

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2022 108.78M +55.72%
Dec 31, 2021 69.86M -47.20%
Dec 31, 2020 132.3M +60.81%
Dec 31, 2019 82.27M +52.87%
Dec 31, 2018 53.82M -53.38%
Dec 31, 2017 115.45M +137.41%
Dec 31, 2016 48.63M -18.96%
Jun 30, 2016 60M -29.86%
Jun 30, 2015 85.54M +42.82%
Jun 30, 2014 59.9M +68.55%
Jun 30, 2013 35.53M +117.25%
Jun 30, 2012 16.36M -15.27%
Jun 30, 2011 19.3M +38.46%
Jun 30, 2010 13.94M -50.18%
Jun 30, 2009 27.99M -30.46%
Jun 30, 2008 40.25M +5.33%
Jun 30, 2007 38.21M +19.09%
Jun 30, 2006 32.09M -10.16%
Jun 30, 2005 35.72M +37.61%
Jun 30, 2004 25.96M +240.26%
Jun 30, 2003 7.63M +29.67%
Jun 30, 2002 5.88M +31.33%
Jun 30, 2001 4.48M -59.94%
Jun 30, 2000 11.18M +202.18%
Jun 30, 1999 3.7M +516.67%
Jun 30, 1998 600K +50.00%
Jun 30, 1997 400K -20.00%
Jun 30, 1996 500K n/a
Jun 30, 1995 500K -44.44%
Jun 30, 1994 900K -47.06%
Jun 30, 1993 1.7M -37.04%
Jun 30, 1992 2.7M -20.59%
Jun 30, 1991 3.4M +240.00%
Jun 30, 1990 1M +25.00%
Jun 30, 1989 800K n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.